V. Di Giacomo

Predicting the probability of Gaucher disease in subjects with splenomegaly and thrombocytopenia

D. Consonni, A. Patriarca, M. Filocamo, 2021, Scientific Reports.

Usefulness of an ad hoc questionnaire (Acro-CQ) for the systematic assessment of acromegaly comorbidities at diagnosis and their management at follow-up

F. Guaraldi, G. Beccuti, S. Grottoli, 2016, Journal of Endocrinological Investigation.

Health‐related quality of life and burden of fatigue in patients with primary immune thrombocytopenia by phase of disease

F. Mandelli, G. Gaidano, F. Cottone, 2016, American journal of hematology.

Methimazole-Induced Agranulocytosis and Quick Recovery with G-CSF

A. Alonci, C. Musolino, L. Calabrò, 2001, Hematology.

Response Assessment to Erythropoietin-Zeta (Epo-Alpha Biosimilar) Therapy in Low-Risk Myelodysplastic Syndromes

C. Vetro, F. Di Raimondo, M. Vadala', 2022, Journal of clinical medicine.

Gaucher disease prevalence in 600 patients affected by monoclonal gammopathy of undetermined significance

M. Ragusa, V. Innao, U. Consoli, 2023, European journal of haematology.